U058 Medical and Technological Advancements for the Management of Complex Alopecias
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
This session will focus on the rise of emerging technologies for the management of alopecia. The following will be reviewed: artificial intelligence, platelet rich plasma, exosomes landscape, novel laser technology, hydradermabrasion, hair transplantation, and and regenerative medicine.
LEARNING OBJECTIVES
Discuss the novel medical and procedural technologies available for the management of the alopecia patient
Discuss the artificial intelligence for the assessment of alopecia
Discuss technological advancements in hair transplantation
SCHEDULE
12:00 PM
Top medical and technological pearls to know for 2025 in alopecia
Ronda S. Farah, MD, FAAD
12:06 PM
Hydradermabrasion- basics and advancements in scalp health
Suleima Arruda, MD, IFAAD
12:12 PM
Artificial intelligence updates for the hair loss clinics
Maria K. Hordinsky, MD, FAAD
12:20 PM
Exosomes: regulatory landscape pearls every clinician should know
Ronda S. Farah, MD, FAAD
12:30 PM
Platelet Rich Plasma and Combination Procedural Options for Alopecia
Neil S. Sadick, MD, FAAD
12:40 PM
Dermatology need to knows for hair transplant patients
Marc R. Avram, MD, FAAD
12:50 PM
Q&A
SPEAKERS
Suleima Arruda, MD, IFAAD
Marc R. Avram, MD, FAAD
Ronda S. Farah, MD, FAAD
Maria K. Hordinsky, MD, FAAD
Neil S. Sadick, MD, FAAD
HANDOUTS
SPEAKER DISCLOSURES
Suleima Arruda, MD, IFAAD
Venus Concept – Consultant(Stock Options);
Marc R. Avram, MD, FAAD
Lumenis Be Ltd. – Consultant (1099 relationship)(Honoraria);
Ronda S. Farah, MD, FAAD
American Academy of Dermatology – Other(Grants/Research Funding); Arcutis, Inc. – Investigator(Grants/Research Funding); ASLAN Pharmaceuticals – Investigator(Grants/Research Funding); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Early Sullivan Wright Gizer & McRae LLP – Consultant (1099 relationship)(Fees); Eli Lilly – Investigator(Grants/Research Funding); Lumenis Be Ltd. – Consultant (1099 relationship)(Fees); Novartis – Advisory Board(Fees); Pfizer – Investigator(Grants/Research Funding); Pfizer Inc. – Stockholder(No Compensation Received), Stockholder Public Company(No Compensation Received); Technoderma Medicines – Investigator(Grants/Research Funding);
Maria K. Hordinsky, MD, FAAD
AbbVie – Advisory Board(Fees); Arcutis Biotherapeutics – Investigator(Grants/Research Funding); Cassiopea – Investigator(Grants/Research Funding); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Grants/Research Funding); National Alopecia Areata Foundation – Investigator(Grants/Research Funding); RegenLab – Investigator(Grants/Research Funding); Sun Pharmaceuticals – Investigator(Grants/Research Funding); UpToDate, Inc – Other(Fees);
Neil S. Sadick, MD, FAAD
AbbVie – Consultant(Fees); Aclaris Therapeutics Inc. – Investigator(Grants/Research Funding); Acorn Biolabs – Speaker(Honoraria); Advalight – Investigator(Grants/Research Funding), Speaker(Honoraria); Allergan, Inc. – Consultant(Honoraria); Alma Lasers, Inc. – Investigator(Equipment), Investigator(Grants/Research Funding); American Academy of Dermatology – Speaker(No Compensation Received); American Hair Research Society – Board of Directors(No Compensation Received); American Society of Dermatologic Surgery – Speaker(No Compensation Received); Amgen – Investigator(Grants/Research Funding); ASLAN – Investigator(Grants/Research Funding); Aurigene Discovery Technologies Ltd – Independent Contractor(Grants/Research Funding); Bausch Health – Investigator(Grants/Research Funding); Bellus Health – Investigator(Grants/Research Funding); Biorasi, LLC – Investigator(Grants/Research Funding); Biosion – Investigator(Grants/Research Funding); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Canfield Scientific, Inc. – Other(Equipment); Cara Therapeutics – Investigator(Grants/Research Funding); Castle Biosciences – Investigator(Grants/Research Funding); Cell Research Corp – Consultant (1099 relationship)(Honoraria); Celldex – Investigator(Grants/Research Funding); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Corvus Pharmaceuticals – Investigator(Grants/Research Funding); Cutera, Inc. – Other(Equipment), Speaker(Honoraria); Derm Advance – Stockholder(Stock Options); Derm Tech International – Consultant(Fees), Investigator(Grants/Research Funding); Dermira – Investigator(Grants/Research Funding); Distinct Dermatology – Stockholder Private Company(Stock Options); Dr Reddy's Laboratory – Investigator(Grants/Research Funding); Eirion Therapeutics – Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding); EndyMed Medical Inc. USA – Speaker(Honoraria); Fortrea – Investigator(No Compensation Received); Foundation for Research & Education of Dermatology – Advisory Board(Honoraria), Speaker/Faculty Education(Fees); Galderma USA – Investigator(Grants/Research Funding); Gerson Lehrman Group – Consultant(Honoraria); GlaxoSmithKline Immunology – Investigator(Grants/Research Funding); Highlightll Pharmaceutical – Investigator(Grants/Research Funding); ICON plc. – Investigator(No Compensation Received); IMCAS – Speaker/Faculty Education(Honoraria), Speaker/Faculty Education(Other Financial Benefit); Incyte Corporation – Investigator(Grants/Research Funding); Informa – Other(Other Financial Benefit); Innovaderm Research Inc. – Investigator(No Compensation Received); Janssen Pharmaceuticals, Inc – Investigator(Grants/Research Funding); Kimera Labs, Inc – Speaker(Honoraria); L'Oreal USA Inc. – Advisory Board(Fees), Consultant (1099 relationship)(Fees); LCN Consulting – Consultant(Fees); LEO Laboratories Ltd (LEO Pharma) – Investigator(Grants/Research Funding); Lumenis Be Ltd. – Consultant(Fees), Investigator(Grants/Research Funding); Lumisque – Speaker(Honoraria); Meiji Seika Pharma Co., Ltd – Investigator(Grants/Research Funding); Merz Aesthetics – Investigator(Grants/Research Funding); Nektar Therapeutics – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); NFlection Therapeutics, Inc – Investigator(Grants/Research Funding); NUMAB Therapeutics AG – Investigator(Grants/Research Funding); Paraxel Therapeutics, Inc – Investigator(No Compensation Received); Pfizer Inc. – Investigator(Grants/Research Funding); PPD Inc. – Investigator(Grants/Research Funding); Rho Inc. – Investigator(Grants/Research Funding); Sanofi – Investigator(Equipment), Investigator(Grants/Research Funding); Scientus Pharma Inc. – Stockholder(Stock Options); Shaperon – Investigator(Equipment), Investigator(Grants/Research Funding); Syneos Health – Investigator(No Compensation Received); Takeda Pharmaceuticals USA Inc – Investigator(Grants/Research Funding); Taylor & Francis – Other(Other Financial Benefit); UCB – Investigator(Equipment), Investigator(Grants/Research Funding); Union Therapeutics – Investigator(Grants/Research Funding); Venus Concept – Investigator(Grants/Research Funding), Other(Equipment), Stockholder(Stock Options); VeraDermics Inc. – Investigator(Grants/Research Funding); Vial – Investigator(No Compensation Received); Vydence Medical – Other(Equipment), Speaker(Honoraria); WeThrivv – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria), Stockholder Private Company(Stock Options);